Summarized by Masters of Longevity from Peter Attia Blog.
A longform conversation on how cancer science has shifted across prevention, early detection, metabolism, immunotherapy, and regenerative biology with a clinical perspective.
Key Takeaways
- Hyperinsulinemia and altered cancer metabolism are emerging as actionable contributors to cancer risk and treatment strategies.
- Immunotherapies and CAR T cells have produced durable remissions, with some patients remaining disease-free for over a decade.
- Researchers lack a validated inflammation biomarker for cancer risk comparable to cholesterol for cardiovascular disease.
